My Portfolio
+
LINK YOUR PORTFOLIO

Bio-Techne Corp TECH:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 4:07 PM EDT
50.85UNCH (UNCH)
Volume
46,914
Close
50.85quote price arrow up+1.08 (+2.17%)
Volume
2,179,556
52 week range
43.20 - 72.16
Loading...
  • Open49.58
  • Day High50.89
  • Day Low49.04
  • Prev Close49.77
  • 52 Week High72.16
  • 52 Week High Date01/22/26
  • 52 Week Low43.20
  • 52 Week Low Date05/15/26

Key Stats

  • Market Cap7.962B
  • Shares Out156.57M
  • 10 Day Average Volume2.60M
  • Dividend0.32
  • Dividend Yield0.63%
  • Beta1.36

KEY STATS

  • Open49.58
  • Day High50.89
  • Day Low49.04
  • Prev Close49.77
  • 52 Week High72.16
  • 52 Week High Date01/22/26
  • 52 Week Low43.20
  • 52 Week Low Date05/15/26
  • Market Cap7.962B
  • Shares Out156.57M
  • 10 Day Average Volume2.60M
  • Dividend0.32
  • Dividend Yield0.63%
  • Beta1.36

RATIOS/PROFITABILITY

  • EPS (TTM)0.69
  • P/E (TTM)73.73
  • Fwd P/E (NTM)25.11
  • EBITDA (TTM)378.945M
  • ROE (TTM)5.28%
  • Revenue (TTM)1.211B
  • Gross Margin (TTM)66.42%
  • Net Margin (TTM)8.96%
  • Debt To Equity (MRQ)9.59%

EVENTS

  • Earnings Date08/04/2026(est)
  • Ex Div Date05/18/2026
  • Div Amount0.08
  • Split Date-
  • Split Factor-

Profile

MORE
Bio-Techne Corporation develop, manufacture and sell life science reagents, instruments and services for the research, diagnostics and bioprocessing markets worldwide. The Company’s segments include Protein Sciences segment and Diagnostics and Spatial Biology segment. The Protein Sciences segment is a developer and manufacturer of purified proteins and reagent solutions, most notably cytokines and growth factors, antibodies, immunoassays, biologically active small molecule...
Robert Baumgartner CPA
Independent Chairman of the Board
Kim Kelderman
President, Chief Executive Officer, Director
James Hippel
Chief Financial Officer, Executive Vice President - Finance
Address
614 Mckinley Pl N E, Suite 1500
Minneapolis, MN
55413
United States